Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.77
+0.16 (2.10%)
At close: Nov 5, 2025, 4:00 PM EST
7.90
+0.13 (1.67%)
After-hours: Nov 5, 2025, 7:19 PM EST
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $252.69 million as of November 5, 2025. Its market cap has increased by 42.15% in one year.
Market Cap
252.69M
Enterprise Value
117.38M
1-Year Change
42.15%
Ranking
Category
Stock Price
$7.77
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $252.69M, a decrease of -28.78%. That is a compound annual growth rate of -13.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 252.69M | 74.42% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 788.35B |
| Johnson & Johnson | 451.96B |
| AbbVie | 379.99B |
| UnitedHealth Group | 298.95B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.52B |